We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Facility Inspections Factor in Slow Generics Reviews, Says GAO
Facility Inspections Factor in Slow Generics Reviews, Says GAO
The FDA is improving its response times for generic drug applications, but facility inspections remain a major hang-up in the process, according to a GAO report.